Two Sigma Securities’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-4,637
| Closed | -$371K | – | 1924 |
|
|
2026
Q1 | $371K | Buy |
+4,637
| New | +$382K | 0.04% | 628 |
|
|
2025
Q4 | – | Sell |
-12,720
| Closed | -$989K | – | 1633 |
|
|
2025
Q3 | $989K | Buy |
+12,720
| New | +$994K | 0.15% | 169 |
|
|
2025
Q2 | – | Sell |
-4,180
| Closed | -$303K | – | 1661 |
|
|
2025
Q1 | $303K | Buy |
+4,180
| New | +$299K | 0.05% | 583 |
|
|
2024
Q4 | – | Sell |
-22,825
| Closed | -$1.51M | – | 2146 |
|
|
2024
Q3 | $1.51M | Buy |
22,825
+20,419
| +849% | +$1.48M | 0.03% | 670 |
|
|
2024
Q2 | $222K | Buy |
+2,406
| New | +$213K | ﹤0.01% | 2268 |
|
|
2023
Q4 | – | Sell |
-7,392
| Closed | -$514K | – | 3182 |
|
|
2023
Q3 | $512K | Buy |
+7,392
| New | +$594K | 0.01% | 1520 |
|
|
2023
Q1 | – | Sell |
-2,780
| Closed | -$219K | – | 2825 |
|
|
2022
Q4 | $207K | Sell |
2,780
-1,079
| -28% | -$83.2K | 0.01% | 1925 |
|
|
2022
Q3 | $319K | Buy |
+3,859
| New | +$371K | 0.01% | 1507 |
|
|
2020
Q3 | – | Sell |
-3,200
| Closed | -$221K | – | 1394 |
|
|
2020
Q2 | $221K | Buy |
+3,200
| New | +$227K | 0.01% | 1080 |
|
|
2019
Q4 | – | Sell |
-3,897
| Closed | -$304K | – | 2408 |
|
|
2019
Q3 | $286K | Buy |
+3,897
| New | +$274K | ﹤0.01% | 1591 |
|
|
2018
Q4 | – | Sell |
-55,050
| Closed | -$2.79M | – | 2337 |
|
|
2018
Q3 | $3.2M | Buy |
55,050
+29,130
| +112% | +$1.42M | 0.02% | 518 |
|
|
2018
Q2 | $1.26M | Buy |
25,920
+342
| +1% | +$16K | 0.01% | 1195 |
|
|
2018
Q1 | $1.19M | Buy |
+25,578
| New | +$1.11M | 0.01% | 1167 |
|
|
2017
Q4 | – | Sell |
-16,287
| Closed | -$593K | – | 1796 |
|
|
2017
Q3 | $593K | Buy |
16,287
+8,694
| +115% | +$332K | 0.05% | 236 |
|
|
2017
Q2 | $299K | Sell |
7,593
-390
| -5% | -$14.2K | 0.06% | 361 |
|
|
2017
Q1 | $250K | Buy |
+7,983
| New | +$250K | 0.05% | 477 |
|
|
2016
Q4 | – | Sell |
-18,090
| Closed | -$727K | – | 771 |
|
|
2016
Q3 | $727K | Buy |
18,090
+8,094
| +81% | +$305K | 0.25% | 94 |
|
|
2016
Q2 | $332K | Buy |
+9,996
| New | +$342K | 0.18% | 162 |
|
Other funds holding EW
Two Sigma Securities's EW Position: Q2 2026 in Review
Two Sigma Securities sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 4,637 shares — an estimated $371K sold.
Two Sigma Securities first reported a position in EW in Q2 2016 and held it in 18 quarters. The position peaked at $3.2M in Q3 2018. 1,341 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Two Sigma Securities reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
- Two Sigma Securities sold 4,637 Edwards Lifesciences shares in Q2 2026, an estimated $371K.
- Two Sigma Securities first reported a position in Edwards Lifesciences in Q2 2016 and held it in 18 quarters.
- Two Sigma Securities's Edwards Lifesciences position peaked at $3.2M in Q3 2018.
- 1,341 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.